References
- Bild A H, Potti A, Nevins J R. Linking oncogenic pathways with therapeutic opportunities. Nat Rev Cancer 2006; 6: 735–741
- Bassères D S, Baldwin A S. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25: 6817–6830
- Kohno M, Momoi M, Oo M L, Paik J H, Lee Y M, Venkataraman K, et al. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol Cell Biol 2006; 26: 7211–7223
- Cuvillier O, Pirianov G, Kleuser B, Vanek P G, Coso O A, Gutkind S, et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996; 38: 800–803
- Maceyka M, Payne S G, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 2002; 1585: 193–201, Review
- Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat Dec 4, 2007, [Epub ahead of print]
- Xia P, Gamble J R, Wang L, Pitson S M, Moretti P A, Wattenberg B W, et al. An oncogenic role of sphingosine kinase. Curr Biol 2000; 10: 1527–1530
- Spiegel S, Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem 2002; 277: 25851–25854
- French K J, Upson J J, Keller S N, Zhuang Y, Yun J K, Smith C D. Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther 2006; 318: 596–603
- Bayerl M G, Bruggeman R D, Conroy E J, Hengst J A, King T S, Jimenez M, et al. Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions. Leuk Lymphoma 2008; 49: 948–954